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The reported prevalence of post-miscarriage IUAs varies considerably, depending on different parameters including the population studied, the diagnostic method applied and the classification system used. (25) Subsequently, the effect of number of miscarriages and D&C procedures on the rate of IUAs has not been established. We present a systematic review of the literature to evaluate adhesion formation after miscarriage and to identify potential risk factors. We also assessed long-term reproductive outcome following a miscarriage, particularly in women with post-miscarriage IUAs.
Methods
This systematic review and meta-analysis was conducted in accordance with PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Institutional review board approval was not sought since all data were extracted from previously published data.
Systematic searches
We searched the literature for published papers reporting on women who were systematically evaluated by hysteroscopy after miscarriage. The following terms were used in title or abstract searches or as MESH terms: 'abortion', 'miscarriage', 'curettage', 'intrauterine adhesions', 'uterine adhesions', 'Asherman syndrome', 'traumatic amenorrhea', 'endometrial sclerosis', 'adhesive endometriosis', 'post-traumatic intrauterine synechiae', 'uterine synechiae' and 'uterine atresia'. The latter terms have been used in the past for intrauterine adhesions and were therefore included in the search. To be able to compare the long-term reproductive outcomes, a second search was performed for published papers in which key reproductive indicators (conception rate, pregnancy rate and miscarriage rate) in women following a miscarriage, in particular women with post-miscarriage IUAs, were reported. The following terms were used in title or abstract searches or as MESH terms: 'abortion', 'miscarriage', 'curettage', 'fertility', 'infertility', 'pregnancy rate', 'human' and 'reproductive outcome'. The following electronic databases were searched: MEDLINE (1966 to January 2013), EMBASE (1974 to January 2013), Cochrane Central Register of Controlled Trials (CENTRAL). The search terms were modified according to database requirements. The reference lists of the included studies were also hand-searched for additional relevant studies.
Paper selection procedure
All prospective cohort, cross-sectional studies or randomized controlled trials (RCTs) reporting on prevalence, risk factors and/or symptoms of IUAs in women diagnosed with a current miscarriage (first search) and key reproductive indicators following a miscarriage (second search) were considered for inclusion. Original articles had to be published as full papers in peer-reviewed journals while language restrictions were not applied. Case reports and small case series with ,30 patients were not included. Studies were selected independently in a two-stage process by two researchers; the first search was by A.B.H. and J.A.F.H. and the second search was by A.B.H. and M.L. First, eligibility was assessed based on the title and abstract. Full manuscripts were obtained for all studies that were selected. In the second step, examination of the full manuscript was carried out to study the eligibility of the study. Additional information was sought from authors if papers contained insufficient information.
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Eligibility criteria
Studies reporting the prevalence of post-miscarriage IUAs had to include women with a previous miscarriage, in whom within 12 months after spontaneous expulsion or medical or surgical treatment a hysteroscopy was per-formed to study the presence of IUAs. Studies reporting on women after elective abortion were excluded; elective abortion is considered a different clinical condition, implicating the possibility of a difference in adhesion formation. Studies mainly evaluating women because of a history of recurrent miscarriage, without a recent miscarriage within 12 months, were also excluded. These articles evaluated a selective group, women with a history of recurrent miscarriage who did not achieve a new pregnancy, to elucidate possible causal factors. We excluded these studies since we consider them to evaluate a group with a potentially higher prevalence of intrauterine abnormalities, causing the risk of overestimation of IUAs due to selection bias. The presence of IUAs had to be studied as a primary or secondary outcome parameter. A hysteroscopic evaluation of the uterine cavity after miscarriage for the presence of adhesions was obligatory; studies in which other diagnostic methods were used for evaluation were not included. In the second search, studies had to report time to conception, conception rate, pregnancy rates and/or miscarriage rates by natural conception in women with post-miscarriage IUAs and/or women following conservative, medical or surgical management of miscarriage. Studies reporting reproductive outcomes of sub fertile couples or after assisted reproductive treatment (ART) were excluded. Papers describing obstetric complications, apart from miscarriage, in the pregnancy subsequent to miscarriage were also excluded. Women with a history of recurrent miscarriage were excluded. The prevalence of other factors affecting long-term reproductive outcome, such as sub-sequent miscarriage, is expected to be increased in this selected population. By including this group, the relationship between adhesions and subsequent pregnancy outcome is affected and cannot be interpreted because of selection bias. Overall, women had to be included consecutively and independent of their symptoms.
Nomenclature
The nomenclature used to describe clinical events in early pregnancy in this paper was according to the revised terminology by the ESHRE Special Interest Group for Early Pregnancy (SIGEP).(26) A miscarriage was defined as the spontaneous expulsion of products of conception or the disappearance of fetal heart activity on ultrasound or a gestational sac that did not grow in consecutive ultrasound examinations during the first 20 weeks of gestation. A delayed miscarriage, previously named missed abortion, was defined as an anembryonic pregnancy without blood loss or expulsion of products of conception. Women were divided into conservative, medical or surgical treatment groups depending on the treatment received.
Outcome measures
The primary outcome measure was the presence and degree of the reported IUAs. Secondary metaanalyses were performed to estimate the associations between prevalence of IUAs and type of miscarriage, number of miscarriages or number of curettage procedures. Furthermore, the frequencies of both congenital and acquired abnormalities, such as polyps and fibroids, were assessed if reported. Subsequently, in the second analysis, conception, live birth and miscarriage rates and time to conception in women diagnosed with IUAs following a miscarriage were assessed and compared for women after conservative, medical or surgical management of a miscarriage.
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Extent and degree of intrauterine adhesions
To enable evaluation of the extent and degree of IUAs and outline prognosis and results of treatment, a classification system is essential. Over time a variety of updated classifications systems have been used, based on different diagnostic tools, clinical presentation and past reproductive performance. Unfortunately, the classification systems are not uniformly used and none have been validated by clinical studies. (27) The most used IUA classification systems are the classification of March et al., the American Fertility Society (AFS) classification, the European Society of Hysteroscopy (ESH) classification and the European Society of Gynecological Endoscopy (ESGE) classification. In the classification system of March et al. (1978) , the adhesions are categorized in minimal, moderate and severe groups based on a combination of the type of adhesions and cavity involvement. The American Fertility Society (1988) classification of IUAs is based on the extent of cavity involvement, type of adhesions and menstrual pattern. Cumulative scores determine the severity ranging from stage I to III. The ESGE emerged from the ESH; both classifications are based on a combination of the type of adhesions, site and extent of cavity involvement and the presence of amenorrhea or pronounced hypomenorrhea. (28, 29) The severity of the adhesion is classified in seven grades. In order to allow eventual meta-analyses, we re-categorized the severity of adhesions in three categories, based on data extracted from the reported classification system. The categories were defined as mild, moderate or severe depending on the scale of the different classification systems (Table 1) . 
Classification of intrauterine abnormalities
Intrauterine malformations found by hysteroscopy can be divided into congenital and acquired abnormalities. Congenital uterine abnormalities may arise from malformation at any step of the Müllerian developmental process and are classified in different groups, some with further division in subtypes.(30) Acquired intrauterine abnormalities include uterine polyps, leiomyoma, retained products of conception and endometritis. The prevalence of intrauterine abnormalities was calculated for the entire group and furthermore, according to the number of miscarriages.
Data extraction and assessment of methodological quality
The following information was extracted from the included studies: publication year, study design, inclusion and exclusion criteria, patients' characteristics, treatment received, duration of follow-up, evaluation after miscarriage, congenital and acquired intrauterine abnormalities, evaluation of adhesions and IUA occurrence rate. If available, the degree and extent of IUAs were also extracted. 
Data analysis
Statistical analyses were conducted using the Review Manager (RevMan) version 5.0 software (Cochrane Collaboration) and SAS 9.3 (SAS Institute, Cary, NC, USA). For each study separately, the odds ratio (OR) with 95% confidence interval (CI) was calculated for dichotomous variables. The presence of statistical heterogeneity was determined using the I2 statistics. Heterogeneity was considered substantial when I2 was >50%. (32, 33) In order to compare the overall prevalence of IUAs in women following miscarriage and in women with one versus more than one miscarriage, incomplete versus delayed miscarriage or one D&C versus more than one D&C, pooled ORs and 95% confidence intervals (CI) were calculated. Differences in the incidence of IUAs in women with one, two, three or more miscarriages were tested using meta-regression. Depending on the presence of statistical heterogeneity, the data of studies were pooled on the basis of a fixed effects model or a random effects model. Cumulative conception, live birth and miscarriage rates were calculated for women with IUAs after miscarriage and compared for women after conservative, medical or surgical management of the miscarriage. For all tests performed, statistical significance was determined at P <0.05.
Results
Prevalence of post-miscarriage intrauterine adhesions
Using the limitations 'human only' and 'clinical trial', the first search strategy yielded 804 citations including 201 duplicates. The quorum flow diagram illustrating the selection procedure is shown in Figure 1 . Of the 603 remaining articles, 503 were excluded after title and abstract selection as they did not study IUAs in relation to miscarriages. One potential eligible article was not available for full manuscript reviewing even after contacting the author and publisher.(34) After reviewing full manuscripts of the remaining 99 articles, 63 papers were excluded; the reason for exclusion was lack of uterine evaluation after miscarriage. Five articles that used hysterosalpingography for uterine evaluation (35) (36) (37) (38) (39) were also excluded. Additionally, 19 papers were excluded from analysis; 17 articles reported on women evaluated because of recurrent miscarriages in their reproductive history, without a recent miscarriage within 12 months (40-56), one reported on infertile women with a history of curettage (57) and one reported on women after elective induced abortion (58) . Two case series with respectively 3 and 10 women were also excluded. (61), eight prospective cohort studies (62-69) and one prospective cross-sectional study (19) met the inclusions criteria. The characteristics of the included studies are presented in Table 2 . In the only RCT (61), women with a miscarriage were randomized to receive prophylactic doxycycline, prophylactic doxycycline plus conjugated equine estrogen or no treatment for prevention of IUAs following D&C. The prospective cohort study of Tam et al. (2002) was a follow-up study of women enrolled in a previous RCT. In the initial study (70) , women diagnosed with a complete spontaneous miscarriage were managed conservatively; otherwise women were randomly allocated to either D&C or treatment with misoprostol. In one study, women after IVF-embryo transfer with early pregnancy failure were analyzed, but the method of treatment was not stated. (69) In the remaining seven studies (Table 2) , six prospective cohort studies and one cross-sectional study, women diagnosed with a current miscarriage were subjected to D&C and evaluated after surgery for the presence of IUAs. A total of 912 women evaluated by post-miscarriage hysteroscopy were included in the studies, ranging from 53 to 151 women per study, with a mean of 91. The hysteroscopy was performed between 1 and 12 months following the miscarriage. The majority of the 781 patients (86%) were treated by curettage whereas only 22 patients (2.4%) had been treated medically while 25 (2.7%) were evaluated after a spontaneous miscarriage without any intervention. For the remaining 84 women (9.2%), the treatment 2 24 method was not stated. In three studies (19, 67, 68) , 30% of women were lost to follow-up, as shown in Table 2 . Given the substantial proportion of women not revised, inducing some kind of verification bias, a separate analysis was performed excluding these studies. The results of the assessment of the methodological quality of the included studies using the STROBE checklist are reported in Supplementary data, Table SI . The included studies had a mean item score of 17.5 (from 31 relevant items), ranging between 14 and 25. 
Intrauterine adhesions
Overall, IUAs were detected in 183 of the 912 women, resulting in a pooled prevalence of 19.1% (95% CI: 12.8 -27.5%), I 2 = 86%, P <0.001. When the studies with significant numbers lost to follow-up were excluded, the result did not change significantly; the pooled prevalence was 19.7% (95% CI: 12.0 -29.7%). In one study, some of the women were treated by expectant management (n=25) or medically (n=22), and no IUAs were reported in these women. In nine studies women were treated by D&C, and IUAs 25 were identified in 151 of the 781 patients, with a pooled prevalence of 18.5% (95% CI: 12.6 -26.4%), I 2 = 82.5%, P <0.001, while the pooled prevalence did not change significantly when studies with significant numbers lost to follow-up were excluded; 16.3% (95% CI: 11.2 -23.1%). In the 10th study (69) , the treatment method was not mentioned and IUAs were detected in 32 of the 84 patients (38.1%; 95% CI: 28.4 -48.8%). The extent and degree of the adhesions were reported in seven studies accounting for 124 women with adhesions, 67.8% of all women with adhesions. The adhesions were classified according to the ESH/ESGE, AFS and March systems in four, one and one studies, respectively, while in one study the classification system was not stated (Table 2 ). In one article (67), the moderate and severe adhesions of seven patients were not separately reported; we considered these patients to have moderate adhesions. The extent of the reported IUAs is reported in Table 3 ; in 72 patients (58.1%) mild adhesions were reported, in 35 (28.2%) the adhesions were moderate and in 17 (13.7%) the adhesions were severe. 
Numbers of miscarriages
Results of the meta-analysis are summarized in Figure 2 . The data of seven prospective studies were pooled to compare the prevalence of IUAs in women with more than one versus one miscarriage ( Figure 2A ). There were 63 cases of IUAs among 270 women with more than one miscarriage compared with 69 cases among 430 women with one miscarriage, OR 1.99 (95% CI: 1.32 -3.00), I 2 = 0%, P = 0.001. Excluding two studies with significant loss to follow-up resulted in an OR 2.08 (95% CI:1.25-3.48). Women with more than one miscarriage had statistically significantly more IUAs compared with women with one miscarriage. The vast majority of the patients were managed surgically. IUAs were detected in 17 of 77 women with three or more miscarriages compared with 21 cases among 111 women with two miscarriages (Figure 2B ), OR 1.52 (95% CI: 0.68 -3.38), I 2 = 0%, P = 0.30. Excluding one study with significant loss to follow-up resulted in an OR 1.38 (95% CI: 0.57 -3.31). No significant differences in IUAs were found between women with two or three miscarriages. Relative to women with one miscarriage, women with two miscarriages showed no statistical significant risk OR 1.41 (95% CI: 0.78 -2.5) but women with three or more miscarriages showed a statistically significantly increased risk of IUAs OR 2.1 (95% CI: 1.09 -4.1). Figure 2E shows the reported prevalence of IUAs per study as well as the pooled estimates across the three groups.
Type of miscarriage and numbers of D&C procedures
In four studies, there were 68 cases of IUAs among 234 women with an incomplete miscarriage compared with 37 cases of IUAs among 155 women with a delayed miscarriage ( Figure 2C) , with an OR of 1.22 (95% CI: 0.76 -1.96), I2 ¼ 21%, P ¼ 0.41. Excluding two studies with significant loss to followup resulted in OR 1.59 (95% CI: 0.82 -3.10). No significant differences were found in IUAs in the women with incomplete and delayed miscarriage. In seven studies, after more than one D&C, 59 cases of IUAs 2 26 were detected among 253 women compared with 70 cases in 443 women after one D&C (Fig. 2D) 
Intrauterine abnormalities
Seven studies reported on the prevalence of intrauterine abnormalities, other than adhesions, assessed by hysteroscopy. Overall, 150 cases of intrauterine abnormalities were detected in 675 women, resulting in a pooled prevalence of 22.4% (95% CI: 16.3 -29.9%), I 2 = 68.5%, P = 0.001. When the studies with significant loss to follow-up were excluded, the pooled prevalence did not change significantly, 22.0% (95% CI: 15.3 -30.6%). The prevalence of intrauterine abnormalities was 12.5% (34/271) after one miscarriage and 29.4% (55/187) after more than one miscarriage, and the difference was statistically significant, P <0.0001. Congenital abnormalities were reported in 92 women, accounting for 61.3% of all encountered abnormalities. The most reported anomaly was the septate uterus or bicornual uterus in 69 of the 92 women (75.0%), followed by the arcuate uterus (19.6%), hypoplastic uterus (3.3%) and unicornuate uterus in respectively three (3.3%) and two (2.2%) women. The most reported acquired uterine abnormality was uterine polyps in 28 of 58 women (48.3%) with an acquired abnormality, followed by leiomyoma, endometritis and retained products of conception in 15 (25.9%), 10 (17.2%) and 5 (8.6%) women, respectively. The influence of infection or inflammation on the formation of IUAs could not be examined due to insufficient reports of this event while the use of antibiotics was not stated. The effect of estradiol application was studied in three studies, but was insufficient for analysis. Information concerning the indication for, and the method of, performing D&C was not stated. As such, these possible risk factors could not be examined.
Long-term fertility and reproductive outcome
A second literature search was performed for relevant articles reporting on long-term reproductive outcomes in women following a miscarriage, especially in women with post-miscarriage IUAs. The study selection and number of included studies are reported in Figure 3 . In summary, 4553 potentially relevant citations were identified, including 715 duplicates. After title and abstract selection 3694 citations were excluded, because it was clear that they did not fulfill the inclusion criteria. After reviewing the full manuscripts of the remaining 144 articles, 100 were excluded from analysis: 71 articles did not report on follow-up after miscarriage, while 29 articles reported long-term reproductive out-comes in subfertile couples or after assisted conception. Subsequently, 36 articles were excluded including 12 articles reporting on symptomatic women with IUAs, i.e. women with menstrual disturbances and/or infertility. (17, 18, 21, (71) (72) (73) (74) (75) (76) (77) (78) (79) Eleven studies examined the associations between pregnancy and obstetric complications and past reproductive performance in populationbased cohorts and were excluded.(80-90) Seven articles evaluating women with recurrent pregnancy loss (91-97), three case reports (98-100) and one article (101) reporting unplanned conceptions following miscarriage were excluded. Furthermore, two retrospective articles reporting on reproductive outcomes following a miscarriage were excluded. (102, 103) Description and quality of included studies assessing long-term reproductive outcome Finally, eight prospective studies (Table 4) were identified, in which key reproductive indicators following a miscarriage were reported.(5, 104-110) A total of 1770 women who had suffered a miscarriage were included in the eight studies. The results of the assessment of the methodological quality of the eight included prospective studies using the STROBE checklist are reported in Supplementary data, Table SII. The included studies had a mean item score of 14.4 (from 31 relevant items), ranging between 11 and 29. 
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Reproductive outcome following intrauterine adhesions
The relationship between IUAs following a miscarriage and subsequent fertility and reproductive outcome could not be assessed, as the presence of IUAs was not studied in the included eight studies. 
Reproductive outcome following miscarriage
Discussion
To our knowledge, this is the first published systematic review and meta-analysis reporting the prevalence of IUAs after miscarriage and potential risk factors, and long-term reproductive outcome following a miscarriage was also assessed. Hysteroscopy was considered the gold standard for IUA detection; the uterine cavity can be visualized and the extent, localization and degree of IUAs can be accurately determined, while other intrauterine abnormalities can also be detected. 
Summary of the evidence
The prevalence of IUAs in women treated for a current miscarriage varied between 3 and 38%, with a pooled prevalence of 19%. The majority of women were treated by D&C and women with more than one miscarriage had a significantly higher incidence of IUAs than women with only one miscarriage (P =0.001). The prevalence of IUAs was not different in women with two compared with three or more miscarriages or in women with in-complete versus delayed miscarriage, although the small number of included women may have played an important role in this finding; the studies were underpowered to detect a significant difference between the groups. Exclusion of the studies with a substantial number lost to follow-up (.30%), did not influence the results of the meta-analysis. Recurrent curettage procedures were identified as the most import-ant risk factor for IUA formation. In our study, no adhesions were encountered in women after a spontaneous miscarriage without any intervention and in women treated medically, although they were a minority (5.1%). The time between treatment and hysteroscopic evaluation for IUAs ranged between 1 and 12 months. In 42% of the reviewed patients, moderate to severe IUAs were encountered and these are of concern as they may have serious reproductive implications. Besides IUAs, other abnormalities were frequently encountered in women undergoing hysteroscopy after miscarriage, with an overall prevalence of 22.4%. Congenital abnormalities accounted for 61.3% of all encountered intrauterine abnormalities, especially uterine septum or bicornuate uterus. Uterine 31 polyps were the most reported acquired abnormality. The prevalence of intrauterine abnormalities was significantly increased in women with more than one miscarriage compared with women with only one miscarriage. After extensive review of the literature, only eight prospective studies were identified in which key reproductive indicators were reported after conservative, medical or surgical treatment for a miscarriage. Despite the extensive literature search, we were unable to find any study that had specifically looked at reproductive outcome or long-term fertility in women with post-miscarriage IUAs. Only symptomatic women with IUAs of different cause were reported in the available studies on this subject. Similar pregnancy outcomes were reported subsequent to conservative, medical and surgical management of miscarriage, although the number of studies evaluating the long-term reproductive outcome was limited and different time scales were used. The limited number of studies and small sample size of the treatment groups obviously limit the statistical power to detect any difference in reproductive outcomes between the treatment regimes. Due to a large variation in primary outcomes, methodology and populations, we were not able to perform meta-analyses on reproductive outcome after miscarriage. The relation-ship and impact of IUAs on long-term reproductive outcomes remain un-determined. The number of previous miscarriages seems to predict subsequent re-productive performance; the live birth rate declines and the risk of miscarriage increases. (85, 109, 110) As shown by Hure et al. (2012) , different groups of women experience different miscarriage rates; factors such as smoking status and fertility problems have great impact on the miscarriage rate, with an 8-fold difference in the group with the lowest versus the highest calculable rate of miscarriage.
Strengths and limitations of the review
Our study has several points to be highlighted. We performed a systematic review of the literature to determine the prevalence of IUAs and to identify risk factors. Furthermore, long-term reproductive outcome in women after miscarriage was assessed. The strength of this report is that the methodology and quality of included studies were individually analyzed and only studies in peer-reviewed journals were included. Only studies in which participants were included prospectively and consecutively were eligible for inclusion. Studies were included if in all the enrolled patients a validated method for IUA ascertainment was used and IUAs were clearly defined or if key reproductive indicators were used to establish long-term reproductive outcome. We applied this protocol in order to minimize verification bias. For this reason, studies including only symptomatic women after miscarriage were excluded. In addition, we did not include studies reporting the prevalence of IUAs or key reproductive indicators with a retrospective design, or studies in which women were evaluated by hysteroscopy beyond 12 months after miscarriage, given the higher risk of selection bias. This study has also several weaknesses. Unfortunately, only one randomized controlled trail was available to be included in this systematic review; cohort studies are less reliable specially to determine treatment-associated factors. Only ten prospective cohort studies with IUAs as end-point in women diagnosed with a current miscarriage were encountered. The individual studies with a limited number of patients, a maximum 151, are underpowered to evaluate risk and prognostic factors. Despite metaanalysis, the sample sizes in subgroups remained small. The methodological quality of the studies included in this review is considered poor to average. The studies reporting on IUAs, assessed by the STROBE statement checklist, resulted in an average score 2 32 of 17.5 (ranging 14 -25) , of a maximum of 34. Although all patients had experienced a miscarriage and had a hysteroscopic evaluation within 12 months after miscarriage, eligibility criteria, sources and methods of selection of participant were barely described. There was insufficient in-formation in most studies regarding the number of patients who met all inclusion criteria and the reason for received treatment and there were no explanations of how the study sizes were determined. In three studies >30% of women were lost to follow-up and these were the studies with the longest period between miscarriage and hysteroscopic evaluation. This could be a relevant source of bias, as women achieving early pregnancy are excluded. A separate analysis, excluding these studies, did not influence the results significantly. Another noticeable point is that only 5.1% of the women were evaluated after a spontaneous miscarriage and expectant management or after medical evacuation.
Variations in different potential influencing factors including maternal age, chromosomal abnormalities, endocrine diseases, mode of conception and term of pregnancy failure (early and/or late) could not be ruled out. The majority of patients received surgical treatment and no distinction could be made between patients with and without D&C in the subgroups. The indication to perform a surgical treatment (D&C) was not reported. Women requiring surgical treatment (D&C) may differ from those who would be amenable to medical treatment or requiring no treatment at all. Furthermore, there was lack of information concerning the D&C technique (sharp, blunt, suction or combinations), cervical ripening, skills of the surgeons, indication, signs of infection or inflammation, the use of antibiotics and treatment with estradiol. Because different classification systems were used, the scoring of the adhesions was not uniform while the presence of pre-existing adhesions was not assessed. These factors may have biased the results in an unknown way. The methodological quality of the included studies reporting on long-term reproductive outcome was poor. The average STROBE statement score was 14.4, ranging between 11 and 29. A substantial percentage of patients treated medically or conservatively received additional surgical treatment because of incomplete management. Furthermore, no adjustments were made in the studies for confounding variables such as parity, gravidity, infertility, or number of prior induced abortions and miscarriages. The studies did not report on the prevalence of other pathologies; no adjustments were made for intrauterine abnormalities, although they can be detected frequently and contribute to the incidence of miscarriage. In this regard, the result of this review should be interpreted with caution as the overall quality of the included studies reporting on both post-miscarriage IUAs and in particular on the related long-term re-productive outcomes needs to be considered as poor to average. The long-term reproductive outcome could not be reported in women with post-miscarriage IUAs due to a lack of studies reporting on key reproductive indicators in these women. A total of 1770 women were included in eight cohort studies, reporting on one or more long-term reproductive indicators in women following a miscarriage, was a limited number and a small overall sample size. Similar outcomes were reported over different time scales in the different treatment groups, while no adjustment was made in the studies for important con-founding factors. So, on the basis of the current literature no solid conclusions can be drawn on the link between treatment modality and adhesion formation. The issue of possible impairment of future fertility after miscarriage remains inconclusive on basis of the current literature. Systematic reviews and meta-analyses rely on aggregated published data to provide estimates of treatment effects or diagnostic tests. It is not possible to perform detailed analyses that take into account patient covariates or other features. A potentially more coherent approach to summarize the evidence is to acquire the original data from the included studies. Metaanalysis based on individual patient data pre-vents drawbacks and biases compared with conventional review, allowing the possibility of investigating effectiveness in patients with different profiles and 33 offering a more valid outcome.(113) However, to do so, access to original data sets is imperative, which can be a problem in older studies, while authors need to be willing to share their data.
Comparison with previous research
This systematic review and meta-analysis reports the prevalence of IUAs after miscarriage, while no studies were found to report on long-term reproductive outcomes in women with after miscarriage IUAs. The largest study that classified IUAs following different antecedent endometrial trauma, including incomplete or elective abortion and post-partum curettage, showed that the subsequent reproductive outcome after hysteroscopic treatment depends on the extent of IUAs. The pregnancy rate declined from 93% in women with mild to 57% in women with severe IUAs while the term pregnancy rate declined from 88 to 57%. (18) There was a large and statistically significant reduction in surgical treatment when patients were treated with misoprostol compared with immediate D&C, RR 0.07 (95% CI: 0.03 -0.18), without differences in blood transfusion, anemia, pelvic infection or use of pain relief. More-over, women were satisfied with the treatment they received. (122) When there is a necessity, D&C should be performed in the gentlest manner avoiding unnecessary trauma. Application of materials for the prevention or reduction of adhesion may be effective in the prevention of IUAs, although the evidence is limited and only a minority have been studied in women after miscarriage.
Implications for further research
To accurately define the prevalence of IUAs, a systematic and prospective evaluation is required after spontaneous miscarriage and expectant management, medical evacuation and surgical treatment (D&C). After reviewing the literature, no study was encountered in which this was studied. Several randomized studies have been performed comparing treatment strategies for miscarriage, but without systematic follow-up with IUAs as end-point of interest. IUAs is a surrogate indicator: long-term fertility, reproductive outcome and obstetric complications are clinically relevant. There is an association between the presence and extent of IUAs and long-term complications but studies addressing the link, especially in women with after miscarriage IUAs, are lacking. Only symptomatic women with IUAs of different causes are reported in the studies available on this subject. To accurately define the prevalence of IUAs, pregnancy, obstetric and fertility complications, one needs to prospectively follow a large cohort of women after miscarriage for a long period. Subsequently, structural follow-up is necessary to examine cumulative pregnancy, birth and miscarriage rates after conservative, medical and surgical treatment for miscarriage. Furthermore, adjustment should be made for congenital and acquired intrauterine abnormalities as they are frequently encountered and can contribute to miscarriages.
Conclusions
The present review reports IUAs in one of five patients after miscarriage. In >50% the adhesions were of mild severity and extent, but the clinical relevance of these mild adhesions are unknown. Recurrent miscarriage and D&C procedures were identified as the most important risk factors, although other influencing factors could not be ruled out. Data on the link between post-miscarriage IUAs and longterm reproductive outcomes are lacking. Similar reproductive outcomes are reported after conservative, medical and surgical management, although the number of studies and sample size are limited. Furthermore, the quality of the studies was poor to average. a Each item is classified as adequate "1", inadequate "0" or not applicable "NA" in the evaluation of a paper. a Each item is classified as adequate "1", inadequate "0" or not applicable "NA" in the evaluation of a paper.
